Find a Trial

Trial Summary



Notice: Undefined variable: ssqs in C:\xampp\htdocs\clinical_trials.php on line 35
Protocol No.PHO-MERCK-KEYNOTE-667
StatusOPEN TO ACCRUAL
Principal InvestigatorBelsky, Jenny
ScopeNational
PhasePhase II
Age GroupChildren
TitleAn Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)
Applicable Disease SitesHodgkin's Lymphoma
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactHeather Claussen, Phone:
    Pager:
    Email: heclauss@iupui.edu